Page last updated: 2024-08-26

fibrinogen and Peripheral Vascular Diseases

fibrinogen has been researched along with Peripheral Vascular Diseases in 100 studies

Research

Studies (100)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (1.00)	18.7374
1990's	29 (29.00)	18.2507
2000's	62 (62.00)	29.6817
2010's	7 (7.00)	24.3611
2020's	1 (1.00)	2.80

Authors

Authors	Studies
Doelare, SAN; Ebben, HP; Ergin, K; Hoksbergen, AWJ; Jongkind, V; Lely, RJ; Oukrich, S; Wiersema, AM; Yeung, KK	1
Acin, F; Bleda, S; De Haro, J; Esparza, L; López de Maturana, I; Varela, C	1
Allison, MA; Callas, PW; Criqui, MH; Cushman, M	1
Dalgård, C; de Maat, MP; Enghusen-Poulsen, H; Hørder, M; Jonung, T; Morrow, JD; Nielsen, F	1
Baumgartner, I; Diehm, N; Dörffler-Melly, J; Husmann, M; Kalka, C; Silvestro, A	1
Bartlett, JW; De Stavola, BL; Meade, TW	1
Carcaillon, L; Dartigues, JF; Ducimetière, P; Gaussem, P; Giroud, M; Ritchie, K; Scarabin, PY	1
Acsády, G; Selmeci, L; Seres, L; Soós, P; Székely, M	1
Azuma, K; Ebina, T; Hirawa, N; Mitsuhashi, H; Mochida, Y; Nakazawa, I; Sugano, T; Tamura, K; Toya, Y; Tsurumi-Ikeya, Y; Uchino, K; Umemura, S; Wakui, H	1
Raabe, RD	1
Emich-Widera, E; Kopyta, I; Marszał, E; Sarecka-Hujar, B; Zak, I	1
Dhangana, R; Murphy, TP; Pencina, MJ; Zafar, AM	1
Clore, J; Garvey, WT; Hunter, SJ; Jenkins, AJ; Klein, RL; Semler, AJ; Zheng, D	1
Ducobu, J; Ledent, T; Lefebvre, P	1
Chan, C; Criqui, MH; Fornage, M; Green, D; Greenland, P; Guralnik, JM; Liu, K; Martin, G; McDermott, MM; Pearce, WH; Quann, M; Ridker, PM; Rifai, N; Schneider, JR; Taylor, L	1
Anthony, JP; Borsa, JJ; Burkart, DJ; Thurlo, SR	1
Bachoo, P; Brittenden, J; Cassar, K; Ford, I; Greaves, M	1
Cafferata, HT; Chow, BK; DePalma, RG; Hall, MR; Hayes, VW; Mohammadpour, HA; Zacharski, LR	1
Chan, C; Criqui, MH; Green, D; Greenland, P; Guralnik, JM; Liu, K; McDermott, MM; Pearce, WH; Ridker, PM; Rifai, N; Schneider, JR; Taylor, L	1
Brevetti, G; Bucur, R; Di Donato, A; Di Giacomo, S; Schiano, V; Scopacasa, F; Silvestro, A	1
Budinsky, A; Doweik, L; Maca, T; Minar, E; Sabeti, S; Schillinger, M	1
Chandler, WL; Hoffer, EK; Nicholls, SC	1
Chung, NA; Lip, GY; Makin, AJ; Silverman, SH	1
INGRAM, GI	1
Connor, JM; Cooke, A; Fowkes, FG; Lee, AJ; Lowe, GD; Rumley, A; Smith, FB	1
Biro, F; Kuegler, C; Michler, E; Rudofsky, G; Strubel, G	1
Amighi, J; Exner, M; Minar, E; Mlekusch, W; Muellner, M; Rumpold, H; Sabeti, S; Schillinger, M; Wagner, O	1
Brevetti, G; Oliva, G; Ruocco, A; Schiano, V; Scopacasa, F; Silvestro, A; Zincarelli, C	1
Hull, JE; Hull, MK; Urso, JA	1
Homer-Vaniasinkam, S; Naseem, KM; Nicolaou, A; Riba, R; Troxler, M	1
Erlinger, TP; Selvin, E	1
Chan, C; Criqui, MH; Ferrucci, L; Green, D; Greenland, P; Guralnik, JM; Liu, K; McDermott, MM; Oskin, SI; Pearce, WH; Ridker, PM; Schneider, JR; Taylor, LM	1
Kobayashi, S; Maesato, K; Moriya, H; Ohtake, T; Okamoto, K	1
Brancati, FL; Folsom, AR; Hirsch, AT; Pankow, JS; Selvin, E; Wattanakit, K; Weatherley, BD	1
Criqui, MH; Guallar, E; Lima, JA; Nasir, K; Navas-Acien, A	1
Albay, M; Bandinelli, S; Corsi, A; Ferrucci, L; Guralnik, JM; Macchi, C; McDermott, MM	1
Borozanov, V; Bosevski, M; Kostoska, S; Tosev, S	1
Cheng, SW; Cheuk, BL; Cheung, GC; Lau, SS	1
Chen, J; He, J; Muntner, P; Sutton-Tyrrell, K; Wildman, RP	1
Chin-Dusting, J; Dart, AM; Jackson, S; Kling, D; Kulkarni, S; Woollard, KJ	1
Fowkes, FG; Lee, AJ; Lowe, GD; Murray, GD; Price, JF; Rumley, A; Smith, FB; Tzoulaki, I	1
Dippel, EJ; Kapalis, MJ; Kirchner, HL; Lemke, JH; Palabrica, T; Robken, J; Shammas, NW; Takes, V	1
Dimitroulis, D; Kakisis, JD; Kaperonis, EA; Kostakis, AG; Liapis, CD; Papavassiliou, VG; Perrea, D	1
Bevelacqua, V; Bevelacqua, Y; Libra, M; Malaponte, G; Mazzarino, MC; Navolanic, PM; Polesel, J; Signorelli, SS; Stivala, F; Talamini, R	1
Akaba, N; Ishimaru, S; Iwai, T; Shigematsu, H; Tsuchida, H; Umezu, S	1
Hiramoto, JS; Lane, JS; Lane, KT; Messina, LM; Vittinghoff, E	1
Bickel, C; Blankenberg, S; Espinola-Klein, C; Lackner, K; Munzel, T; Rupprecht, HJ; Schnabel, R	1
Bounameaux, H; de Moerloose, P; Hayoz, D	1
Fatourou, EM; Hamilton, G; Mikhailidis, DP; Paraskevas, KI; Seifalian, AM	1
Bianchi, C; Caricato, F; Civitelli, A; Del Prato, S; Miccoli, R; Pancani, F; Pellegrini, G; Penno, G; Piaggesi, A	1
Bailey, KR; Kardia, SL; Khawaja, FJ; Kullo, IJ; Mosley, TH; Turner, ST	1
Baker, DM; Mikhailidis, DP; Paraskevas, KI; Vrentzos, GE	1
Malaponte, G; Mazzarino, MC; Signorelli, SS; Spandidos, DA	1
Brescia, P; Coratelli, P; Plantamura, M; Quaranta, D; Ramunni, A; Ria, R	1
Kaplan, AA	1
Schiffl, H	1
Cook, NR; Creager, MA; Pradhan, AD; Ridker, PM; Rifai, N; Shrivastava, S	1
Eaton, CB; Lu, B; Parker, D	1
Daskalopoulos, ME; Daskalopoulou, SS; Geroulakos, G; Holloway, P; Kakkos, SK; Mayo, NE; Mikhailidis, DP; Pathmarajah, M	1
Collen, D; Lacroix, H; Stockx, L; Vanderschueren, S; Verhaeghe, R; Vermylen, J; Wilms, G	1
Assmann, G; Heinrich, J; Köhler, E; Schönfeld, R; Schulte, H	1
Binaghi, F; Cannas, F; Caredda, E; Fronteddu, PF; Garau, P; Pitzus, F; Uras, A	1
Bonino, F; Fabris, F; Macchione, C; Molaschi, M; Neirotti, M; Poli, L; Ponzetto, M	1
Kauhanen, P; Lassila, R; Lepäntalo, M; Manninen, V; Peltonen, S; Saarinen, O	1
Donnan, PT; Fowkes, FG; Housley, E; Lowe, GD; Rumley, A; Rumley, AG; Smith, FB	1
Catapano, G; Di Bello, V; Ferrari, M; Giusti, C; Materazzi, F; Melillo, E; Mosca, F; Pedrinelli, R; Santoro, G; Talarico, L	1
Dawes, J; Donnan, PT; Fowkes, FG; Housley, E; Lennie, SE; Lowe, GD	1
Poredos, P; Zizek, B	1
Castiglioni, C; Criqui, M; Longoni, A; Violi, F	1
Arosio, E; Bosello, O; Ferrari, M; Guidi, GC; Lucchese, L; Prior, M	1
Burgmann, H; Ehringer, H; Graninger, W; Hollenstein, U; Koppensteiner, R; Maca, T; Thalhammer, F; Zedwitz-Liebenstein, K	1
Graf, J; Reininger, AJ; Reininger, CB; Schweiberer, L; Spannagl, M; Steckmeier, B	1
Molcányiová, A; Tkác, I	1
Lowe, GD; Woodburn, KR	1
Cisar, LA; Kim, HC; Kostis, JB; Philipp, CS; Saidi, P; Wilson, AC	1
Ernst, E; Koenig, W	1
Fowkes, FG; Lee, AJ; Leng, GC; Lowe, GD; Rumley, A; Smith, FB	1
Barbod, A; Berga, C; Diaz, J; Espinosa, A; Martin-Paredero, V; Richard, CM; Sanchez, J; Segura, J; Vadillo, J; Villaverde, C	1
Cheng, SW; Lau, H; Ting, AC; Wong, J	1
Fowkes, FG; Lee, AJ; Lowe, GD; Mowbray, PI; Price, JF; Rumley, A	1
Connor, JM; Fowkes, FG; Lee, AJ; Lowe, GD; Rumley, A	1
Coppola, L; Cozzolino, D; De Lucia, D; Gentile, S; Masi, S; Salvatore, T; Sasso, FC; Torella, R	1
Beattie, DK; Davies, AH; Greenhalgh, RM; Sian, M	1
Fowkes, FG; Hau, CM; Lee, AJ; Lowe, GD; Rumley, A; Smith, FB	1
Jagroop, IA; Mikhailidis, DP; Milionis, HJ	1
Atwal, AS; Davis, M; Hamilton, G; Jagroop, IA; Mikhailidis, DP; Nair, DR; Seifalian, AM	1
Clement, DL; De Buyzere, M; Delanghe, J; Duprez, D; Langlois, M	1
Budinsky, AC; Sinzinger, H; Wolfram, RM	1
Assmann, G; Heinrich, J; Koehler, E; Schulte, H; Tataru, MC; von Eckardstein, A	1
Ridker, PM; Rifai, N; Stampfer, MJ	1
Andrioli, G; Arosio, E; De Marchi, S; Fontana, L; Gaino, S; Lechi, A; Lechi, C; Minuz, P; Prior, M; Zuliani, V	1
de Gaetano, G; Donati, MB; Iacoviello, L	1
Lip, GY; Makin, A; Silverman, SH	1
Ascari, E; Ferrari, R; Galeazzi, G; Portera, C; Raddino, R; Sarasso, L; Scarabelli, TM; Visioli, O	1
Ahmadi, R; Exner, M; Haumer, M; Minar, E; Mlekusch, W; Rumpold, H; Schillinger, M; Wagner, O	1
Flavell, DM; Hawe, E; Humphries, SE; Jamshidi, Y; MacCallum, PK; Meade, TW	1
Connor, JM; Donnan, PT; Fowkes, FG; Lowe, GD; Smith, FB; Wood, J	1
de Bart, AC; de Knijff, P; Frants, RR; Havekes, LM; Kluft, C	1
Lunetta, M; Salanitri, T	1
Boschetti, C; Catalano, M; Cofrancesco, E; Cortellaro, M; de Gaetano, G; Gabrielli, L; Lombardi, B; Specchia, G; Tavazzi, L; Zanussi, C	1

Reviews

12 review(s) available for fibrinogen and Peripheral Vascular Diseases

Article	Year
[Recent progress in the "fibrinogen hypothesis"]. Revue medicale de Bruxelles, 2003, Volume: 24, Issue:2 Topics: Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Diabetes Complications; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Peripheral Vascular Diseases; Risk Factors	2003
Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease. Thrombosis research, 2003, Volume: 112, Issue:4 Topics: Aged; Angina Pectoris; Antigens, CD; Antigens, Surface; Arterial Occlusive Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Intermittent Claudication; Lectins, C-Type; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; NK Cell Lectin-Like Receptor Subfamily B; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Risk Factors; Scotland; Smoking	2003
[Peripheric arteriopathy: focus in 2007]. Revue medicale suisse, 2007, Feb-07, Volume: 3, Issue:97 Topics: Antifibrinolytic Agents; Atherosclerosis; Biomarkers; E-Selectin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Risk Factors; Serine Proteinase Inhibitors; Vitamin B 6	2007
The role of established and emerging risk factors in peripheral vascular graft occlusion. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:7 Topics: C-Reactive Protein; Cholesterol; Coronary Artery Bypass; Diabetes Mellitus; Fibrinogen; Graft Occlusion, Vascular; Homocysteine; Humans; Hypertension; Lipoprotein(a); Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Factors; Smoking; Vascular Surgical Procedures	2007
The role of fibrinogen and fibrinolysis in peripheral arterial disease. Thrombosis research, 2008, Volume: 122, Issue:1 Topics: Age Distribution; Aged; Atherosclerosis; Fibrinogen; Fibrinolysis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Peripheral Vascular Diseases	2008
Proinflammatory circulating molecules in peripheral arterial disease. International journal of molecular medicine, 2007, Volume: 20, Issue:3 Topics: C-Reactive Protein; Cell Adhesion Molecules; Cytokines; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Inflammation Mediators; Interleukin-6; Matrix Metalloproteinases; Models, Biological; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide	2007
Selective fibrinogen apheresis for improvement in microvascular hemodynamics. Blood purification, 2007, Volume: 25, Issue:5-6 Topics: Blood Component Removal; Cholesterol, LDL; Fibrinogen; Hemodynamics; Humans; Microcirculation; Peripheral Vascular Diseases	2007
Fibrinogen, fibrin turnover, endothelial products and vascular surgery. The British journal of surgery, 1997, Volume: 84, Issue:8 Topics: Arteriosclerosis; Biomarkers; Blood Vessel Prosthesis; Fibrin; Fibrinogen; Humans; Peripheral Vascular Diseases; Plasminogen Inactivators; Thrombosis; von Willebrand Factor	1997
Fibrinogen and cardiovascular risk. Vascular medicine (London, England), 1997, Volume: 2, Issue:2 Topics: Arterial Occlusive Diseases; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Fibrinogen; Humans; Myocardial Ischemia; Peripheral Vascular Diseases; Reference Values; Risk Factors	1997
Assessment of peripheral arterial vascular disease with radionuclide techniques. Seminars in nuclear medicine, 2001, Volume: 31, Issue:2 Topics: Animals; Arterial Occlusive Diseases; Blood Platelets; Fibrinogen; Humans; Immunoglobulins; Indium Radioisotopes; Lipoproteins; Monocytes; Muscles; Nuclear Medicine; Organotechnetium Compounds; Peptides; Peripheral Vascular Diseases; Porphyrins; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed	2001
Peripheral vascular disease and Virchow's triad for thrombogenesis. QJM : monthly journal of the Association of Physicians, 2002, Volume: 95, Issue:4 Topics: Arteries; Blood Coagulation Disorders; Blood Coagulation Factors; Fibrin Fibrinogen Degradation Products; Fibrinogen; Homocysteine; Humans; Peripheral Vascular Diseases; Regional Blood Flow; Thrombosis	2002
[Clinical implications of rheology in cardiovascular diseases]. Recenti progressi in medicina, 2002, Volume: 93, Issue:3 Topics: Adult; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cerebrovascular Disorders; Child; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Leukemia; Leukocytes; Malaria; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Thrombosis	2002

Trials

20 trial(s) available for fibrinogen and Peripheral Vascular Diseases

Article	Year
Supplementation with orange and blackcurrant juice, but not vitamin E, improves inflammatory markers in patients with peripheral arterial disease. The British journal of nutrition, 2009, Volume: 101, Issue:2 Topics: Antioxidants; Beverages; Biomarkers; C-Reactive Protein; Citrus sinensis; Dietary Supplements; Female; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Multivariate Analysis; Oxidative Stress; Peripheral Vascular Diseases; Ribes; Statistics, Nonparametric; Vitamin E; von Willebrand Factor	2009
Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease. Journal of vascular surgery, 2008, Volume: 48, Issue:5 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Ankle; Arterial Occlusive Diseases; Brachial Artery; C-Reactive Protein; Female; Femoral Artery; Fibrinogen; Humans; Inflammation Mediators; Intermittent Claudication; Ischemia; Leukocyte Count; Lower Extremity; Male; Middle Aged; Peripheral Vascular Diseases; Popliteal Artery; Prospective Studies; Regional Blood Flow; Time Factors; Treatment Outcome; Ultrasonography; Vasodilation	2008
Sustained inhibition of oxidized low-density lipoprotein is involved in the long-term therapeutic effects of apheresis in dialysis patients. Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:5 Topics: Aged; Ankle Brachial Index; Biomarkers; Blood Component Removal; C-Reactive Protein; Cell Proliferation; Cells, Cultured; Down-Regulation; Endothelial Cells; Enzyme Activation; Female; Fibrinogen; Humans; Inflammation; Kidney Diseases; Lipoproteins, LDL; Male; Middle Aged; Nitric Oxide Synthase Type III; Peripheral Vascular Diseases; Recovery of Function; Renal Dialysis; Time Factors; Treatment Outcome; Walking	2010
D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation, 2003, Jul-01, Volume: 107, Issue:25 Topics: Aged; Ankle; Biomarkers; Brachial Artery; C-Reactive Protein; Cohort Studies; Exercise Test; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lower Extremity; Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Serum Amyloid A Protein; Walking	2003
Cytokine signatures in atherosclerotic claudicants. The Journal of surgical research, 2003, May-15, Volume: 111, Issue:2 Topics: Aged; Aged, 80 and over; Aging; Arteriosclerosis; Blood Glucose; C-Reactive Protein; Cholesterol; Cytokines; Ferritins; Fibrinogen; Glycated Hemoglobin; Humans; Interleukin-10; Interleukin-2; Interleukin-6; Iron; Middle Aged; Peripheral Vascular Diseases; Phlebotomy; Tumor Necrosis Factor-alpha	2003
Failure of peripheral arterial thrombolysis due to elevated plasminogen activator inhibitor type 1. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2003, Volume: 14, Issue:8 Topics: Female; Fibrinogen; Humans; Male; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombin Time; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Treatment Failure; Urokinase-Type Plasminogen Activator	2003
Thrombogenesis and endothelial damage/dysfunction in peripheral artery disease. Relationship to ethnicity and disease severity. Thrombosis research, 2003, Volume: 111, Issue:4-5 Topics: Aged; Arteries; Arteriosclerosis; Asian People; Biomarkers; Black People; Causality; Comorbidity; Endothelium, Vascular; Female; Fibrinogen; Humans; Intermittent Claudication; Male; P-Selectin; Peripheral Vascular Diseases; Risk Assessment; Risk Factors; Severity of Illness Index; Statistics as Topic; Thromboplastin; Thrombosis; United Kingdom; von Willebrand Factor; White People	2003
Eptifibatide in peripheral vascular interventions: results of the Integrilin Reduces Inflammation in Peripheral Vascular Interventions (INFLAME) trial. The Journal of invasive cardiology, 2006, Volume: 18, Issue:1 Topics: Aged; Aneurysm, False; Anticoagulants; Biomarkers; Dose-Response Relationship, Drug; Eptifibatide; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Inflammation; Injections, Intravenous; Male; Middle Aged; Peptides; Peripheral Vascular Diseases; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin; Time Factors; Whole Blood Coagulation Time	2006
Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS). International angiology : a journal of the International Union of Angiology, 2006, Volume: 25, Issue:3 Topics: Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Erythrocytes; Exercise Test; Exercise Tolerance; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Hypercholesterolemia; Intermittent Claudication; Ischemia; Japan; Lower Extremity; Male; Microcirculation; Middle Aged; Peripheral Vascular Diseases; Plasmapheresis; Plethysmography; Recovery of Function; Severity of Illness Index; Spectroscopy, Near-Infrared; Treatment Outcome; Triglycerides	2006
Fibrinogen apheresis in the treatment of peripheral arterial disease. Blood purification, 2007, Volume: 25, Issue:5-6 Topics: Aged; Aged, 80 and over; Blood Component Removal; Endothelium, Vascular; Exercise Tolerance; Female; Fibrinogen; Hemodynamics; Humans; Lower Extremity; Male; Microcirculation; Middle Aged; Peripheral Vascular Diseases; Skin; Treatment Outcome; Walking	2007
Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs. Angiology, 1994, Volume: 45, Issue:2 Topics: Arterial Occlusive Diseases; beta-Thromboglobulin; Blood Coagulation; Blood Viscosity; Double-Blind Method; Erythrocyte Deformability; Fibrinogen; Hemorheology; Humans; Intermittent Claudication; Male; Middle Aged; Peripheral Vascular Diseases; Photoplethysmography; Phthalic Acids; Platelet Aggregation Inhibitors	1994
Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study. Atherosclerosis, 1996, Volume: 120, Issue:1-2 Topics: Adult; Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Comorbidity; Diabetes Mellitus; Disease Susceptibility; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Incidence; Italy; Leukocyte Count; Logistic Models; Male; Middle Aged; Odds Ratio; Peripheral Vascular Diseases; Phthalic Acids; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Thromboxane; Risk Factors; Smoking; Vascular Surgical Procedures	1996
Lipoprotein(a) and general risk factors in patients with angiographically assessed peripheral arterial disease. International angiology : a journal of the International Union of Angiology, 1995, Volume: 14, Issue:4 Topics: Adult; Aged; Arterial Occlusive Diseases; Body Constitution; Body Mass Index; Case-Control Studies; Cholesterol; Female; Fibrinogen; Humans; Hypertension; Lipoprotein(a); Male; Middle Aged; Peripheral Vascular Diseases; Prospective Studies; Radiography; Regression Analysis; Risk Factors; Smoking	1995
Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. European heart journal, 1999, Volume: 20, Issue:5 Topics: Aged; Arterial Occlusive Diseases; Biomarkers; Blood Pressure; Blood Viscosity; Cholesterol; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Lipoproteins; Male; Middle Aged; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires; United Kingdom	1999
Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1. European journal of clinical pharmacology, 1999, Volume: 55, Issue:7 Topics: Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Glycated Hemoglobin; Humans; Iloprost; Insulin; Male; Middle Aged; Peripheral Vascular Diseases; Pilot Projects; Plasminogen; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Risk Factors; Time Factors; Treatment Outcome; Walking	1999
The effect of short-term lipid lowering with atorvastatin on carotid artery intima media thickness in patients with peripheral vascular disease: a pilot study. Current medical research and opinion, 2000, Volume: 16, Issue:3 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Carotid Arteries; Cholesterol; Exercise Test; Female; Fibrinogen; Heptanoic Acids; Homocysteine; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Pilot Projects; Pyrroles; Statistics, Nonparametric; Tunica Intima; Tunica Media; Ultrasonography	2000
Vascular adhesion molecule-1 and markers of platelet function before and after a treatment with iloprost or a supervised physical exercise program in patients with peripheral arterial disease. Life sciences, 2001, Jun-15, Volume: 69, Issue:4 Topics: Aged; Arteriosclerosis; Blood Glucose; Blood Pressure; Cholesterol; Endothelium, Vascular; Exercise; Fibrinogen; Humans; Iloprost; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Activation; Platelet Function Tests; Treatment Outcome; Triglycerides; Vascular Cell Adhesion Molecule-1	2001
Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial. Atherosclerosis, 2002, Volume: 163, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Apolipoprotein C-III; Apolipoproteins C; Arterial Occlusive Diseases; Base Sequence; Bezafibrate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fibrinogen; Follow-Up Studies; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Hypolipidemic Agents; Male; Middle Aged; Molecular Sequence Data; Peripheral Vascular Diseases; Polymerase Chain Reaction; Polymorphism, Genetic; Probability; Reference Values; Sensitivity and Specificity; Treatment Outcome	2002
Lowering of plasma viscosity by the oral administration of the glycosaminoglycan sulodexide in patients with peripheral vascular disease. The Journal of international medical research, 1992, Volume: 20, Issue:1 Topics: Administration, Oral; Adult; Blood Coagulation; Blood Viscosity; Double-Blind Method; Female; Fibrinogen; Glycosaminoglycans; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Thrombosis	1992
The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients. Atherosclerosis, 1991, Volume: 90, Issue:2-3 Topics: Aged; Antithrombin III; Arteriosclerosis; Blood Coagulation Factors; Electrocardiography; Female; Fibrinogen; Hemostasis; Humans; Intracranial Arteriosclerosis; Lipids; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Prospective Studies; Protein C; Risk Factors; Smoking	1991

Other Studies

68 other study(ies) available for fibrinogen and Peripheral Vascular Diseases

Article	Year
Major Bleeding During Thrombolytic Therapy for Acute Lower Limb Ischaemia: Value of Laboratory Tests for Clinical Decision Making, 17 Years of Experience. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2023, Volume: 65, Issue:3 Topics: Arterial Occlusive Diseases; Clinical Decision-Making; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Ischemia; Peripheral Vascular Diseases; Prospective Studies; Retrospective Studies; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Urokinase-Type Plasminogen Activator	2023
Inflammatory burden predicts long-term outcomes in endovascular therapy in peripheral arterial disease. Annals of vascular surgery, 2013, Volume: 27, Issue:4 Topics: Biomarkers; C-Reactive Protein; Endovascular Procedures; Fibrinogen; Follow-Up Studies; Humans; Peripheral Vascular Diseases; Prognosis; Prospective Studies; Reoperation; Risk Factors; Spain; Survival Rate; Time Factors; Vasculitis	2013
Inflammation and peripheral venous disease. The San Diego Population Study. Thrombosis and haemostasis, 2014, Sep-02, Volume: 112, Issue:3 Topics: Aged; Biomarkers; C-Reactive Protein; California; Chemokine CCL2; Cytokines; Disease Progression; E-Selectin; Female; Fibrinogen; Humans; Inflammation Mediators; Intercellular Adhesion Molecule-1; Male; Middle Aged; Peripheral Vascular Diseases; Population Groups; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A; Veins	2014
Assessing the contribution of fibrinogen in predicting risk of death in men with peripheral arterial disease. Journal of thrombosis and haemostasis : JTH, 2009, Volume: 7, Issue:2 Topics: Aged; Aged, 80 and over; Cause of Death; Death; Fibrinogen; Humans; Male; Middle Aged; Models, Statistical; Odds Ratio; Peripheral Vascular Diseases; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk; Survival Analysis	2009
Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study. Journal of thrombosis and haemostasis : JTH, 2009, Volume: 7, Issue:12 Topics: Age Factors; Aged; Biomarkers; Cohort Studies; Dementia, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Incidence; Male; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Stroke; von Willebrand Factor	2009
Assay of oxidized fibrinogen reactivity (OFR) as a biomarker of oxidative stress in human plasma: the role of lysine analogs. Clinical chemistry and laboratory medicine, 2010, Volume: 48, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aminocaproates; Apoprotein(a); Biomarkers; Female; Fibrinogen; Humans; Kinetics; Lysine; Male; Middle Aged; Oxidative Stress; Peripheral Vascular Diseases; Tranexamic Acid	2010
Ultrasound-accelerated thrombolysis in arterial and venous peripheral occlusions: fibrinogen level effects. Journal of vascular and interventional radiology : JVIR, 2010, Volume: 21, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Combined Modality Therapy; Down-Regulation; Drug Administration Schedule; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Parenteral; Male; Middle Aged; Peripheral Vascular Diseases; Radiography; Retrospective Studies; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonic Therapy; Vascular Patency; Venous Thrombosis; Washington; Young Adult	2010
Association between lipids and fibrinogen levels and ischemic stroke in the population of the Polish children with arteriopathy and cardiac disorders. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2010, Volume: 63, Issue:1 Topics: Adolescent; Child; Cohort Studies; Comorbidity; Female; Fibrinogen; Heart Diseases; Humans; Lipid Metabolism; Male; Peripheral Vascular Diseases; Poland; Risk Factors; Stroke; Triglycerides	2010
Prevalence of low ankle-brachial index, elevated plasma fibrinogen and CRP across Framingham risk categories: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Atherosclerosis, 2011, Volume: 216, Issue:1 Topics: Adult; Aged; Ankle Brachial Index; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Nutrition Surveys; Peripheral Vascular Diseases; Prevalence; Risk Assessment; Risk Factors; Time Factors; United States; Up-Regulation	2011
Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort. Diabetes care, 2003, Volume: 26, Issue:5 Topics: Adenine; Adult; Albuminuria; Base Sequence; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; DNA Primers; Female; Fibrinogen; Guanine; Humans; Male; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Regression Analysis	2003
Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study. Journal of vascular and interventional radiology : JVIR, 2003, Volume: 14, Issue:6 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Disease-Free Survival; Drug Therapy, Combination; Eptifibatide; Female; Femoral Artery; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Hematocrit; Hemoglobins; Hemorrhage; Humans; Iliac Artery; Iliac Vein; Lower Extremity; Male; Middle Aged; Missouri; Peptides; Peripheral Vascular Diseases; Pilot Projects; Platelet Aggregation Inhibitors; Popliteal Artery; Popliteal Vein; Prospective Studies; Tenecteplase; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Vena Cava, Inferior; Venous Thrombosis	2003
Platelet activation is increased in peripheral arterial disease. Journal of vascular surgery, 2003, Volume: 38, Issue:1 Topics: Aged; Female; Fibrinogen; Flow Cytometry; Humans; Intermittent Claudication; Ischemia; Lower Extremity; Male; Middle Aged; P-Selectin; Peripheral Vascular Diseases; Platelet Activation; Prospective Studies	2003
Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. The American journal of cardiology, 2003, Jul-15, Volume: 92, Issue:2 Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Pressure; Brachial Artery; C-Reactive Protein; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Inflammation Mediators; Male; Middle Aged; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Prothrombin; Serine Proteinase Inhibitors; Serum Amyloid A Protein; Severity of Illness Index; Tissue Plasminogen Activator	2003
Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. Journal of vascular surgery, 2003, Volume: 38, Issue:2 Topics: Aged; Arteriosclerosis; Biomarkers; Blood Circulation; C-Reactive Protein; Cross-Sectional Studies; Endothelium, Vascular; Female; Fibrinogen; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Risk Factors	2003
Fibrinogen predicts mortality in high risk patients with peripheral artery disease. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2003, Volume: 26, Issue:4 Topics: Aged; Aged, 80 and over; Arteriosclerosis; Biomarkers; Female; Fibrinogen; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Factors; Survival Rate	2003
Plasma fibrinogen concentration in occlusive arterial disease. Edinburgh medical journal, 1952, Volume: 59, Issue:2 Topics: Arterial Occlusive Diseases; Fibrin; Fibrinogen; Humans; Peripheral Vascular Diseases; Vascular Diseases	1952
Influence of fibrinogen and hematocrit on the early outcome of angioplasty in patients with PAOD. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2004, Volume: 11, Issue:2 Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Humans; Ischemia; Male; Middle Aged; Peripheral Vascular Diseases; Treatment Outcome	2004
Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. European heart journal, 2004, Volume: 25, Issue:9 Topics: Aged; Apolipoproteins; C-Reactive Protein; Death, Sudden, Cardiac; Disease-Free Survival; Female; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Neutrophils; Peripheral Vascular Diseases; Prospective Studies; Serum Amyloid A Protein; Treatment Outcome	2004
Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease. Vascular medicine (London, England), 2003, Volume: 8, Issue:4 Topics: Aged; Biomarkers; Brachial Artery; C-Reactive Protein; Case-Control Studies; Endothelium, Vascular; Female; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Regional Blood Flow; Vascular Cell Adhesion Molecule-1; Vasodilation	2003
Reteplase with or without abciximab for peripheral arterial occlusions: efficacy and adverse events. Journal of vascular and interventional radiology : JVIR, 2004, Volume: 15, Issue:6 Topics: Abciximab; Analysis of Variance; Antibodies, Monoclonal; Arterial Occlusive Diseases; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Male; Peripheral Vascular Diseases; Recombinant Proteins; Retrospective Studies; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome	2004
Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels. Atherosclerosis, 2004, Volume: 175, Issue:1 Topics: Adenosine Diphosphate; Aged; Blood Platelets; Fibrinogen; Flow Cytometry; Homocysteine; Humans; Intermittent Claudication; Middle Aged; Nitric Oxide; Nitric Oxide Donors; P-Selectin; Peripheral Vascular Diseases; Platelet Activation; S-Nitrosoglutathione; Sulfhydryl Compounds	2004
Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation, 2004, Aug-10, Volume: 110, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure Determination; Brachial Artery; C-Reactive Protein; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus; Female; Fibrinogen; Glomerular Filtration Rate; Health Surveys; Humans; Hypercholesterolemia; Hypertension; Kidney Diseases; Male; Middle Aged; Peripheral Vascular Diseases; Prevalence; Racial Groups; Risk Factors; Smoking; Tibial Arteries; United States	2004
Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease. Journal of the American Geriatrics Society, 2004, Volume: 52, Issue:11 Topics: Aged; Biomarkers; C-Reactive Protein; Cholesterol; Cross-Sectional Studies; Disability Evaluation; Female; Fibrinogen; Geriatric Assessment; Humans; Inflammation; Male; Peripheral Vascular Diseases; Serum Amyloid A Protein; Statistics, Nonparametric; Thrombosis; Walking	2004
LDL-apheresis improves peripheral arterial occlusive disease with an implication for anti-inflammatory effects. Journal of clinical apheresis, 2005, Volume: 20, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; C-Reactive Protein; Chemokine CCL2; Female; Fibrinogen; Hemofiltration; Humans; Inflammation; Ischemia; Lipoproteins, LDL; Male; Middle Aged; Peripheral Vascular Diseases	2005
Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis, 2005, Volume: 180, Issue:2 Topics: Arteriosclerosis; Cohort Studies; Coronary Artery Disease; Diabetes Complications; Female; Fibrinogen; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Peripheral Vascular Diseases; Risk Factors; Smoking; Tunica Intima	2005
Relationship of monocyte count and peripheral arterial disease: results from the National Health and Nutrition Examination Survey 1999-2002. Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:9 Topics: Aged; Ankle; Atherosclerosis; Biomarkers; Blood Pressure; Brachial Artery; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Monocytes; Nutrition Surveys; Peripheral Vascular Diseases; Prevalence; Risk Factors	2005
Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study. American heart journal, 2005, Volume: 150, Issue:2 Topics: Aged; Aged, 80 and over; alpha-Macroglobulins; Biomarkers; Body Mass Index; C-Reactive Protein; Cholesterol; Comorbidity; Cytokines; Female; Fibrinogen; Health Surveys; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukins; Italy; Male; Middle Aged; Motor Activity; Peripheral Vascular Diseases; Pulse; Sampling Studies; Serum Albumin; Sialoglycoproteins; Smoking; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2005
Prognostic importance of haemostatic parameters in polyarterial disease. Prilozi, 2005, Volume: 26, Issue:1 Topics: Aged; Coronary Artery Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Prognosis	2005
Plasma fibrinogen level: an independent risk factor for long-term survival in Chinese patients with peripheral artery disease? World journal of surgery, 2005, Volume: 29, Issue:10 Topics: Aged; Atherosclerosis; Biomarkers; Female; Fibrinogen; Hong Kong; Humans; Male; Peripheral Vascular Diseases; Risk Factors; Survival Analysis	2005
Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002. The American journal of cardiology, 2005, Dec-01, Volume: 96, Issue:11 Topics: Adult; Aged; Biomarkers; Blood Pressure; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Nutrition Surveys; Odds Ratio; Peripheral Vascular Diseases; Prevalence; Retrospective Studies; Risk Factors; United States	2005
Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion. Circulation research, 2006, Jan-06, Volume: 98, Issue:1 Topics: Aged; Arterial Occlusive Diseases; Cell Adhesion; Female; Fibrinogen; Humans; Leukocytes; Male; Middle Aged; Neutrophils; P-Selectin; Peripheral Vascular Diseases	2006
Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study. American journal of epidemiology, 2006, Feb-15, Volume: 163, Issue:4 Topics: Aged; Arteriosclerosis; C-Reactive Protein; Disease Progression; Female; Fibrinogen; Hemostasis; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Peripheral Vascular Diseases; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Surveys and Questionnaires; Time Factors	2006
Inflammation and Chlamydia pneumoniae infection correlate with the severity of peripheral arterial disease. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2006, Volume: 31, Issue:5 Topics: Aged; Antibodies, Bacterial; Atherosclerosis; C-Reactive Protein; Case-Control Studies; Chlamydophila pneumoniae; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation Mediators; Male; Middle Aged; Peripheral Vascular Diseases; Severity of Illness Index; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1	2006
Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease. Journal of clinical pathology, 2006, Volume: 59, Issue:2 Topics: Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Interleukin-6; Male; Middle Aged; Peripheral Vascular Diseases; Polymorphism, Genetic; Vascular Endothelial Growth Factor A	2006
Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002. Journal of vascular surgery, 2006, Volume: 44, Issue:2 Topics: Age of Onset; Ankle; Blood Pressure; Brachial Artery; Coronary Artery Disease; Demography; Female; Fibrinogen; Health Surveys; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Nutrition Surveys; Peripheral Vascular Diseases; Prevalence; Risk Factors; United States	2006
Inflammation, atherosclerotic burden and cardiovascular prognosis. Atherosclerosis, 2007, Volume: 195, Issue:2 Topics: Aged; Biomarkers; Carotid Artery Diseases; Coronary Angiography; Coronary Artery Disease; Female; Femoral Artery; Fibrinogen; Follow-Up Studies; Germany; Humans; Inflammation; Interleukin-18; Laser-Doppler Flowmetry; Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Prognosis; Prospective Studies; Ultrasonography	2007
Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes. Diabetes research and clinical practice, 2007, Volume: 78, Issue:2 Topics: Aged; Ankle; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Italy; Logistic Models; Male; Middle Aged; Peripheral Vascular Diseases; Prevalence; Pulse; Risk Factors; Smoking	2007
Association of novel risk factors with the ankle brachial index in African American and non-Hispanic white populations. Mayo Clinic proceedings, 2007, Volume: 82, Issue:6 Topics: Ankle; Black or African American; C-Reactive Protein; Female; Fibrinogen; Homocysteine; Humans; Linear Models; Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Risk Factors; White People	2007
Fibrinogen apheresis and peripheral vascular disease: some progress? Blood purification, 2007, Volume: 25, Issue:5-6 Topics: Blood Component Removal; Fibrinogen; Humans; Peripheral Vascular Diseases; Treatment Outcome	2007
Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk. Circulation, 2008, Feb-12, Volume: 117, Issue:6 Topics: Biomarkers; C-Reactive Protein; Cholesterol, HDL; Creatinine; Female; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Lipoprotein(a); Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Prospective Studies; Risk Assessment	2008
Relationship of periodontal attachment loss to peripheral vascular disease: an analysis of NHANES 1999-2002 data. Atherosclerosis, 2008, Volume: 200, Issue:1 Topics: Adult; Aged; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Nutrition Surveys; Odds Ratio; Periodontal Attachment Loss; Peripheral Vascular Diseases	2008
Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. Circulation journal : official journal of the Japanese Circulation Society, 2008, Volume: 72, Issue:3 Topics: Aged; Ankle; Brachial Artery; C-Reactive Protein; Cholesterol, LDL; Creatinine; Cross-Sectional Studies; Diabetes Complications; Dyslipidemias; Female; Fibrinogen; Humans; Hypertension; Intermittent Claudication; Linear Models; Male; Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Risk Factors; Smoking	2008
Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase. Circulation, 1995, Oct-15, Volume: 92, Issue:8 Topics: Female; Fibrinogen; Fibrinolytic Agents; Humans; Immunoglobulin G; Infusions, Intra-Arterial; Male; Metalloendopeptidases; Middle Aged; Peripheral Vascular Diseases; Pilot Projects; Radiography; Recombinant Proteins; Thromboembolism; Thrombolytic Therapy; Vascular Patency	1995
Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thrombosis and haemostasis, 1995, Volume: 73, Issue:3 Topics: Acute-Phase Reaction; Arteriosclerosis; Biomarkers; Blood Coagulation; Blood Glucose; Blood Pressure; Blood Proteins; Body Mass Index; C-Reactive Protein; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Intracranial Arteriosclerosis; Lipids; Lipoproteins; Male; Middle Aged; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Prospective Studies; Radiography; Risk Factors; Severity of Illness Index; Smoking	1995
Prevalence of peripheral arterial occlusive disease and associated risk factors in a sample of southern Sardinian population. International angiology : a journal of the International Union of Angiology, 1994, Volume: 13, Issue:3 Topics: Adult; Aged; Arterial Occlusive Diseases; Diabetes Mellitus; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Italy; Male; Middle Aged; Obesity; Peripheral Vascular Diseases; Prevalence; Risk Factors; Smoking; Surveys and Questionnaires	1994
Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arteriosclerosis and thrombosis : a journal of vascular biology, 1993, Volume: 13, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Arteriosclerosis; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Humans; Male; Middle Aged; Peptide Hydrolases; Peripheral Vascular Diseases; Radiography; Ultrasonography	1993
Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease. Atherosclerosis, 1993, Volume: 102, Issue:2 Topics: Aged; Arteriosclerosis; beta-Thromboglobulin; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Lipid Peroxides; Male; Middle Aged; Peripheral Vascular Diseases; Plasminogen Inactivators; Random Allocation; Smoking; von Willebrand Factor	1993
Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients. Arteriosclerosis and thrombosis : a journal of vascular biology, 1993, Volume: 13, Issue:6 Topics: Administration, Oral; Aged; Albuminuria; Angiography; Arteriosclerosis; Blood Glucose; Blood Pressure; C-Peptide; Echocardiography; Fibrinogen; Glucose; Humans; Hyperinsulinism; Hypertrophy, Left Ventricular; Insulin; Lipids; Male; Middle Aged; Peripheral Vascular Diseases	1993
Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation, 1993, Volume: 87, Issue:6 Topics: Aged; Arteriosclerosis; Blood Coagulation; Blood Viscosity; Cross-Sectional Studies; Female; Fibrinogen; Humans; Intermittent Claudication; Leukocyte Elastase; Male; Middle Aged; Pancreatic Elastase; Peripheral Vascular Diseases; Scotland	1993
Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease. Angiology, 1996, Volume: 47, Issue:3 Topics: Aged; Aged, 80 and over; alpha-Macroglobulins; Arteriosclerosis; Blood Glucose; Blood Viscosity; Cholesterol; Disease Progression; Female; Fibrinogen; Humans; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Peripheral Vascular Diseases; Plasma; Prognosis; Risk Factors	1996
Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease. Journal of clinical pathology, 1996, Volume: 49, Issue:6 Topics: Angiogenesis Inducing Agents; Arterial Occlusive Diseases; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Laminin; Male; Middle Aged; Peripheral Vascular Diseases; Proteins; Ribonuclease, Pancreatic	1996
Increased platelet and coagulatory activity in peripheral atherosclerosis flow mediated platelet function is a sensitive and specific disease indicator. International angiology : a journal of the International Union of Angiology, 1996, Volume: 15, Issue:4 Topics: Antithrombin III; Arteriosclerosis; Blood Coagulation; Blood Coagulation Tests; Blood Flow Velocity; Blood Platelets; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Peptide Hydrolases; Peripheral Vascular Diseases; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Sensitivity and Specificity	1996
Fibrinogen and albuminuria are related to the presence and severity of peripheral arterial disease in women with type 2 diabetes mellitus. Angiology, 1997, Volume: 48, Issue:8 Topics: Aged; Albuminuria; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Lipids; Middle Aged; Peripheral Vascular Diseases; Regression Analysis; Risk Factors	1997
Association of hemostatic factors with peripheral vascular disease. American heart journal, 1997, Volume: 134, Issue:5 Pt 1 Topics: Aged; Blood Coagulation Factors; Blood Pressure; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Logistic Models; Male; Middle Aged; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Risk Factors; von Willebrand Factor	1997
Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication. Journal of vascular surgery, 1998, Volume: 28, Issue:1 Topics: Blood Viscosity; Disease Progression; Female; Fibrinogen; Hemorheology; Humans; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Prognosis; Prospective Studies; Regional Blood Flow; Smoking	1998
Fibrinogen and fibrinolysis in blood and in the arterial wall: its role in advanced atherosclerotic disease. Cardiovascular surgery (London, England), 1998, Volume: 6, Issue:5 Topics: Aorta, Abdominal; Aortic Diseases; Arteriosclerosis; Carotid Artery Diseases; Case-Control Studies; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Interleukin-6; Muscle, Smooth, Vascular; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Popliteal Artery; Risk Factors; Urokinase-Type Plasminogen Activator	1998
Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong. World journal of surgery, 1999, Volume: 23, Issue:2 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Arteriosclerosis; China; Demography; Diabetes Mellitus; Female; Femoral Artery; Fibrinogen; Hong Kong; Humans; Hypercholesterolemia; Hyperglycemia; Hyperlipoproteinemias; Hypertension; Hypertriglyceridemia; Ischemia; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Peripheral Vascular Diseases; Popliteal Artery; Prevalence; Prospective Studies; Risk Factors; Sex Factors; Smoking	1999
Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study. Thrombosis and haemostasis, 1999, Volume: 81, Issue:4 Topics: Aged; Alleles; Arteriosclerosis; Coronary Artery Disease; Cross-Sectional Studies; Factor VII; Female; Fibrinogen; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Polymerase Chain Reaction; Polymorphism, Genetic; Prospective Studies; Risk Factors; Smoking	1999
Influence of systemic factors on pre-existing intimal hyperplasia and their effect on the outcome of infrainguinal arterial reconstruction with vein. The British journal of surgery, 1999, Volume: 86, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Biopsy; Blood Vessel Prosthesis Implantation; Female; Fibrinogen; Graft Rejection; Graft Survival; Homocysteine; Humans; Hyperplasia; Lipoprotein(a); Male; Middle Aged; Peripheral Vascular Diseases; Plastic Surgery Procedures; Saphenous Vein; Treatment Outcome; Tunica Intima	1999
Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2000, Volume: 11, Issue:1 Topics: Aged; Antifibrinolytic Agents; Antigens; Biomarkers; Blood Coagulation Factors; Cohort Studies; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Ischemia; Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Surveys and Questionnaires; Tissue Plasminogen Activator; Urban Population; von Willebrand Factor	2000
Mechanism underlying increased platelet reactivity in patients with peripheral arterial disease. International angiology : a journal of the International Union of Angiology, 1999, Volume: 18, Issue:4 Topics: Anticoagulants; Aspirin; Blood Platelets; Fibrinogen; Heparin; Humans; Peripheral Vascular Diseases; Platelet Adhesiveness	1999
Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation, 2001, Apr-10, Volume: 103, Issue:14 Topics: Aged; Arteriosclerosis; Ascorbic Acid; Aspirin; C-Reactive Protein; Female; Fibrinogen; Humans; Hypertension; Inflammation; Lipids; Male; Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Severity of Illness Index; Smoking	2001
Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Coronary artery disease, 2001, Volume: 12, Issue:3 Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Arteriosclerosis; Cerebrovascular Disorders; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Retrospective Studies; Severity of Illness Index	2001
Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA, 2001, May-16, Volume: 285, Issue:19 Topics: Adult; Aged; Apolipoproteins; Arteriosclerosis; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol; Fibrinogen; Homocysteine; Humans; Likelihood Functions; Lipoprotein(a); Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Prospective Studies; Regression Analysis; Risk Factors; Statistics, Nonparametric	2001
[Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy]. Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2001, Volume: 2, Issue:9 Topics: Arteriosclerosis; Biomarkers; C-Reactive Protein; Cholesterol; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Peripheral Vascular Diseases; Risk Factors	2001
Balloon angioplasty and stent implantation induce a vascular inflammatory reaction. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2002, Volume: 9, Issue:1 Topics: Aged; Angiography; Angioplasty, Balloon; C-Reactive Protein; Case-Control Studies; Chi-Square Distribution; Cohort Studies; Female; Fibrinogen; Humans; Inflammation Mediators; Leukocyte Count; Logistic Models; Male; Middle Aged; Peripheral Vascular Diseases; Probability; Prognosis; Prospective Studies; Reference Values; Sensitivity and Specificity; Serum Amyloid A Protein; Severity of Illness Index; Stents; Vasculitis	2002
Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet (London, England), 1992, Mar-21, Volume: 339, Issue:8795 Topics: Aged; Alleles; Arteriosclerosis; Case-Control Studies; Chromosome Mapping; Female; Fibrinogen; Gene Frequency; Genotype; Haplotypes; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Risk Factors; Smoking	1992
Fibrinogen genes and peripheral arterial disease. Lancet (London, England), 1992, Jul-04, Volume: 340, Issue:8810 Topics: Case-Control Studies; Fibrinogen; Gene Frequency; Humans; Peripheral Vascular Diseases; Selection Bias	1992